-
Unpacking the Power of Movie Soundtracks: How Music Enhances the Film Experience
Lights dim, the screen flickers to life, and the opening credits begin to roll. As the first notes of the movie soundtrack hit our ears, we are transported into a world of storytelling and emotion. Movie soundtracks have the power to elevate the film experience, taking us on an emotional journey and immersing us in…
-
Doing Life Sciences Deals in 2024
Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society). I moderated a panel, “Structuring Your Life Sciences Transaction: Licensing vs. M&A vs. Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.…
-
USPTO Issues Guidance on AI Use to Patent Professionals — AI: The Washington Report
Pursuant to President Biden’s October 2023 executive order on AI, on April 11, 2024, the United States Patent and Trademark Office (USPTO or Office) published “Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States Patent and Trademark Office” in the Federal Register. This notice provides insight into the USPTO’s current stance…
-
Recent Ransomware Attacks Highlight the Evolving Challenges in Responding to Cyber Extortion
A spate of recent ransomware attacks illustrates the increasingly difficult calculations that businesses face following the theft or encryption of their data….By: Patterson Belknap Webb & Tyler LLP
-
Federal Circuit Patent Watch: District Court’s “Seemingly Siloed and Inflexible Approach” to Obviousness “Ran Afoul” of KSR
Precedential and Key Federal Circuit Opinions – 1. JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. [OPINION] (2022-1258, 2022-1307, 4/1/2024) (Dyk, Prost, and Hughes) – Prost, J. The Court affirmed the district court’s indefiniteness determination but vacated and remanded its nonobviousness determination as to the asserted patent….By: WilmerHale
-
The European Parliament Adopts Position on the European Commission’s Proposal for the First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years
In April 2023, we published an alert in relation to two European Commission legislative proposals: new Regulation 2023/0131 and new Directive 2023/0132, to replace the current EU regulatory framework for all medicines (including those for rare diseases and children)….By: Goodwin
-
Chicago Jury Returns $45M Plaintiffs Verdict in Talc Trial
Court: Circuit Court of Cook County, Illinois – On April 19, a Chicago jury ordered Johnson & Johnson to pay $45 million to the family of a Cook County woman named Theresa Garcia who died from mesothelioma, allegedly caused by exposure to asbestos in various talc powder products….By: Goldberg Segalla
-
Florida Jury Returns Defense Verdict in Ovarian Cancer Trial
Court: United States District Court, Middle District of Florida – On Thursday April 18, a Florida jury found the talcum powder in Johnson & Johnson’s baby powder product did not cause the ovarian cancer of deceased Sarasota County resident Patricia Matthey….By: Goldberg Segalla
-
South Texas Oncology and Hematology Experiences Data Breach Following Cyberattack
On April 22, 2023, South Texas Oncology and Hematology (“STOH”) filed a notice of data breach with the Attorney General of Texas after discovering that a recent cyberattack compromised patients’ confidential information. In this notice, STOH explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information, which includes their…
-
Valley Mountain Regional Center Announces July 2023 Data Breach Affecting Patients’ SSNs
On April 19, 2024, Valley Mountain Regional Center (“VRMC”) filed a notice of data breach with the Attorney General of Montana after discovering that an unauthorized party was able to access information stored on the company’s computer network. In this notice, VRMC explains that the incident resulted in an unauthorized party being able to access…
